Gender Differences in Hepatitis C Care Outcomes in the New York City Jail System, 2019–2023: A Retrospective Cohort Study

Clicks: 9
ID: 329478
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #504 of 578 articles by views in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 578 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
BACKGROUND: Significant gaps in hepatitis C (HCV) care outcomes exist between women and men experiencing incarceration, yet limited data examining these differences exist in the literature. Our objective was to examine HCV care outcomes among women and men in a large urban jail. METHODS: A retrospective cohort analysis was completed of all persons incarcerated in the New York City (NYC) jail system who completed a medical intake between 1 October 2019 and 31 December 2023. Logistic regression models were used to calculate odds ratios for women versus men at each HCV care cascade step, including on-site HCV treatment initiation. Jail length of stay, history of mental health needs, homelessness, history of substance use disorders, history of HIV, and number of prior incarcerations in the last year were incorporated into the larger model. RESULTS: Of 71 100 individuals, 7.1% were women. Women had higher rates than men of HIV (3.7% vs 2.8%), mental health needs (55.1% vs 32.0%), select substance use disorders (58.5% vs 45.8%), homelessness (23.5% vs 19.5%) (P < .0001), and shorter jail lengths of stay (19 days vs 30 days, P < .0001). Of those with active HCV seen by an HCV clinician, women had about half the odds of on-site treatment initiation of men (multivariate adjusted odds ratios [AOR] = 0.561, 95% CI = .335-.925). CONCLUSIONS: Women were less likely to initiate jail-based HCV treatment compared to men despite similar infection rates and greater clinical engagement. Gender-focused strategies for HCV care in carceral settings are critical for achieving equitable HCV elimination.
Reference Key
openalex_W7214028293 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Raphael Simonson, Batya Koenigsberg, Natalia Gonzalez Varela, Janet Wiersema, Matthew Jiro Akiyama, Chibuzo Enemchukwu
Journal Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Year 2026
DOI
10.1093/cid/ciag480
URL
https://doi.org/10.1093/cid/ciag480
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.